MESOMARK kit detects C-ERC/mesothelin, but not SMRP with C-terminus

Biochemical and Biophysical Research Communications

Volumn 369, Issue 3, 2008, Pages 915-918

  Segawa, Tatsuya ^a   Hagiwara, Yoshiaki ^a,b   Ishikawa, Kiyoshi ^a   Aoki, Naoko ^a   Maeda, Masahiro ^a   Shiomi, Kazu ^b   Hino, Okio ^b  

^a Immuno Biological Laboratories Co Ltd   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ELISA; ERC mesothelin; Mesothelioma; SMRP; Soluble forms

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; MESOTHELIN; PROTEIN SMRP; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INSERTION; HUMAN; HUMAN CELL; HYDROPHILICITY; MALE; MESOTHELIOMA; MESOTHELIUM; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AGED; ANIMALS; ANTIBODIES; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MESOTHELIOMA; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 41149113813     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.114     Document Type: Article

References (15)

1. Maeda M., and Hino O. Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers. Pathol. Int. 56 (2006) 649-654
2. Maeda M., and Hino O. Blood tests for asbestos-related mesothelioma. Oncology 71 (2006) 26-31
3. Hino O., and Shiomi K. Diagnostic biomarker of asbestos-related mesothelioma: example of translational research. Cancer Sci. 98 (2007) 1147-1157
4. Onda M., Nagata S., Ho M., Bera T.K., Hassan R., Alexander R.H., and Pastan I. Megakaryocyte potentiation factor cleaved from Mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma. Clin. Cancer Res. 12 (2006) 4225-4231
5. Scholler N., Fu N., Yang Y., Ye Z., Goodman G.E., Hellström K.E., and Hellström I.N. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc. Natl. Acad. Sci. USA 96 (1999) 11531-11536
6. Robinson B.W., Creaney J., Lake R., Nowak A., Musk A.W., de Klerk N., Winzell P., Hellstrom K.E., and Hellstrom I. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 362 (2003) 1612-1616
7. Robinson B.W., Creaney J., Lake R., Nowak A., Musk A.W., de Klerk N., Winzell P., Hellstrom K.E., and Hellstrom I. Soluble mesothelin-related protein-A blood test for mesothelioma. Lung Cancer 49S1 (2005) S109-S111
8. Robinson B.W., and Creaney J. Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein. Hematol. Oncol. Clin. North Am. 19 (2005) 1025-1040
9. Hellstrom I., Raycraft J., Kanan S., Sardesai N.Y., Verch T., Yang Y., and Hellstrom K.E. Mesothelin variant 1 is released from tumor cells as a diagnostic marker. Can. Epid. Biomarker Prev. 15 (2006) 1014-1020
10. Hassan R., Remaley A.T., and Sampson M.L. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin. Cancer Res. 12 (2006) 447-453
11. Shiomi K., Miyamoto H., Segawa T., Hagiwara Y., Ota A., Maeda M., Takahashi K., Masuda K., Sakao Y., and Hino O. Novel ELISA system for detection of N-ERC/Mesothelin in the sera of mesothelioma patients. Cancer Sci. 97 (2006) 928-932
12. K. Shiomi, Y. Hagiwara, K. Sonoue, T. Segawa, K. Miyashita, M. Maeda, H. Izumi, K. Masuda, M. Hirabayashi, T. Moroboshi, T. Yoshiyama, A. Ishida, Y. Natori, A. Inoue, M. Kobayashi, Y. Sakao, H. Miyamoto, K. Takahashi, O. Hino, Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma, Clin. Cancer Res., accepted for publication.
13. Pass H.I., Wali A., Tang N., Ivanova A., Ivanov S., Harbut M., Carbone M., and Allard J. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Ann. Thorac. Surg. 85 (2008) 265-272
14. Weber D.G., Taeger D., Pesch B., Kraus T., Brüning T., and Johnen G. Soluble mesothelin-related peptides (SMRP)-High stability of a potential tumor marker for mesothelioma. Cancer Biomark 3 (2007) 287-292
15. Sapede C., Gauvrit A., Barbieux I., Padieu M., Cellerin L., Sagan C., Scherpereel A., Dabouis G., and Grégoire M. Aberrant splicing and protease involvement in mesothelin release from epithelioid mesothelioma cells. Cancer Sci. 99 (2008) 590-594